Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Minerva Ginecol ; 41(7): 359-63, 1989 Jul.
Artigo em Italiano | MEDLINE | ID: mdl-2691924

RESUMO

The present study examines a sample of 98 patients aged 18-77 (mean age 57) and awaiting obstetric or gynaecological surgery who were given short-term prophylaxis with mezlocillin. The overall success rate was 83.67%, partial success 14.28% (against 81% in the controls). In addition to the benefits of a shorter hospital stay and lower operating costs, the treatment produced no side effects.


Assuntos
Cefuroxima/uso terapêutico , Cefalosporinas/uso terapêutico , Mezlocilina/uso terapêutico , Pré-Medicação , Adolescente , Adulto , Idoso , Cesárea , Ensaios Clínicos como Assunto , Avaliação de Medicamentos , Feminino , Genitália Feminina/cirurgia , Ginecologia , Humanos , Pessoa de Meia-Idade , Obstetrícia , Gravidez , Fatores de Tempo
2.
Int J Immunopharmacol ; 8(5): 517-23, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3759298

RESUMO

Monocyte-to-macrophage transformation is a phenomenon which correlates with the absolute number of mononuclear cells, principally lymphocytes, contained in the culture. The addition of cimetidine to cultures of mononuclear cells from the peripheral blood of healthy volunteers enhances monocyte transformation (probably by way of blocking the H2 receptors of suppressors T lymphocytes) regardless of the absolute number of monocytes in the culture or of basal transformation rates. Removal of the lymphocytes from the cultures lowers the basal transformation rate and prevents the effect of cimetidine. The addition of histamine to the cultures causes significant depression of the monocyte transformation rate; this effect is partly offset by the concurrent addition of cimetidine. In the case of cancer patients, mononuclear cell cultures from peripheral blood fail to respond to cimetidine even though basal transformation rates are not significantly different from those of healthy controls; this suggests some intrinsic impairment of monocyte function, possibly mediated by blocking factors produced by the tumor.


Assuntos
Cimetidina/farmacologia , Macrófagos/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Neoplasias/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Diferenciação Celular , Feminino , Humanos , Técnicas In Vitro , Macrófagos/citologia , Macrófagos/imunologia , Masculino , Pessoa de Meia-Idade , Monócitos/citologia , Monócitos/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA